References
1. Abbott, N.J. (2002.) Astrocyte-endothelial interactions and blood-brain barrier permeability. Journal of Anatomy, 200(6), doi:10.1046/j.1469-7580.2002.00064.x
2. Ballabh, P., Maiken, N., & Braun, A. (2004). The blood-brain barrier: An overview: Structure, regulation, and clinical implications. Neurobiology of Disease, 16(1), 1-13.
3. Businaro, R., Leone, S., Fabrizi, C., Sorci, G., Donato, R., Lauro, G., & Fumagalli, L. (2006). S100B protects LAN-5 neuroblastoma cells against A? amyloid- induced neurotoxicity via RAGE engagement at low doses but increases A? amyloid neurotoxicity at high doses. Journal of Neuroscience Research, 83(5), 897-906.
4. Czeisler, B., & Janigro, D. (2006, 06). Reading and Writing the Blood-Brain Barrier: Relevance to Therapeutics. Recent Patents on CNS Drug Discovery, 1(2), 157- 173.
5. Daneman, R., Prat, A. (2015). The Blood – Brain Barrier. Cold Spring Harbor Perspectives in Biology, 7(1).
6. Donato, R. (2001). S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. The International Journal of Biochemistry & Cell Biology, 33(7), 637-668.
7. Erikson, M. A., & Banks, W. A. (2013). Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer’s Disease. Journal of Cerebral Blood Flow & Metabolism, 33(10), 1500-1513.
8. Huttunen, H.J., Kuja-Panula, J., Sorci, G., Agneletti, A.L., Donato, R., Rauvala, H. (2000). Coregulation of Neurite Outgrowth and Cell Survival by Amphoterin and S100 Proteins through Receptor for Advanced Glycation End Products (RAGE) Activation. Journal of Biological Chemistry.. doi:10.1074/jbc.m006993200
9. Kleindienst, A., Mcginn, M. J., Harvey, H. B., Colello, R. J., Hamm, R. J., & Bullock, M. R. (2005, 06). Enhanced Hippocampal Neurogenesis by Intraventricular S100B Infusion Is Associated with Improved Cognitive Recovery after Traumatic Brain Injury. Journal of Neurotrauma, 22(6), 645-655.
10. Kleindienst, A., Hesse, F., Bullock, M. R., & Buchfelder, M. (2007). The neurotrophic protein S100B: Value as a marker of brain damage and possible therapeutic implications. Progress in Brain Research Neurotrauma: New Insights into Pathology and Treatment, 317-325.
11. Kleindienst, A., Schmidt, C., Parsch, H., Emtmann, I., Xu, Y., & Buchfelder, M. (2010, May 24). The Passage of S100B from Brain to Blood Is Not Specifically Related to the Blood-Brain Barrier Integrity. Cardiovascular Psychiatry and Neurology.
12. Marenholz, I., Heizmann, C. W., & Fritz, G. (2004, 10). S100 proteins in mouse and man: From evolution to function and pathology (including an update of the nomenclature). Biochemical and Biophysical Research Communications, 322(4), 1111-1122.
13. Nagele, R.G., Clifford, P.M., Siu, G., Levin, E.C., Acharya, N.K., Han, M., Kosciuk, M.C., Venkataraman, V., Zavareh, S., Zarrabi, S., Kinsler, K., Thaker, N.G., Nagele, E.P., Dash, J., Wang, H.Y., Levitas, A. (2011). Brain- Reactive Autoantibodies Prevalent in Human Sera Increase Intraneuronal Amyloid-?1-42 Deposition. Journal of Alzheimer’s Disease.. doi:10.3233/jad-2011-110098
14. Peña, L. A., Brecher, C. W., & Marshak, D. R. (1995). ? Amyloid regulates gene expression of glial trophic substance S100? in C6 glioma and primary astrocyte cultures. Molecular Brain Research, 34(1), 118-126.
15. Selinfreund, R. H., Barger, S. W., Pledger, W. J., & Eldik, L. J. (1991). Neurotrophic protein S100 beta stimulates glial cell proliferation. Proceedings of the National Academy of Sciences, 88(9), 3554-3558.
16. Sen, J., & Belli, A. (2007). S100B in neuropathologic states: The CRP of the brain? Journal of Neuroscience Research, 85(7), 1373-1380.
17. Sorci, G., Bianchi, R., Riuzzi, F., Tubaro, C., Arzuri, C., Giambanco, I., & Donato, R. (2010). S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond. Cardiovascular psychiatry and neurology, 2010, 656481. doi:10.1155/2010/656481
18. Sparvero, L. J., Asafu-Adjei, D., Kang, R., Tang, D., Amin, N., Im, J., Lotze, M. T. (2009). RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer And inflammation. Journal of translational medicine, 7, 17. doi:10.1186/1479-5876-7-17
19. Wang, L., Wu, J., Guo, X., Huang, X., & Huang, Q. (2017). RAGE Plays a Role in LPS-Induced NF-?B Activation and Endothelial Hyperpermeability. Sensors (Basel, Switzerland), 17(4), 722. doi:10.3390/s17040722
20. Wilson, J. H., & Hunt, T. (2002). Molecular biology of the cell, 4th edition: A problems approach. Garland Science.
21. Wu, H., Brown, E., Acharya, N., Appelt, D., Marks, A., Nagele, R.,Venkataraman, V. (2016). Age-dependent Increase of Blood–Brain Barrier Permeability And Neuron-binding Autoantibodies in S100B Knockout Mice. Brain Research, 1637, 154-167.
22. Yardan, T., Baydin, A., Erenler, A., & Aydin, K. (2011). Usefulness of S100B Protein in Neurological Disorders. Journal of the Pakistan Medical Association, 61(3), 276-281.
